Small vessel disease: mechanisms and clinical implications
JM Wardlaw, C Smith, M Dichgans - The Lancet Neurology, 2019 - thelancet.com
Small vessel disease is a disorder of cerebral microvessels that causes white matter
hyperintensities and several other common abnormalities (eg, recent small subcortical infarcts and …
hyperintensities and several other common abnormalities (eg, recent small subcortical infarcts and …
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
JM Wardlaw, EE Smith, GJ Biessels… - The Lancet …, 2013 - thelancet.com
Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features
seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter …
seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter …
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
JM Wardlaw, C Smith, M Dichgans - The Lancet Neurology, 2013 - thelancet.com
The term cerebral small vessel disease (SVD) describes a range of neuroimaging, pathological,
and associated clinical features. Clinical features range from none, to discrete focal …
and associated clinical features. Clinical features range from none, to discrete focal …
Thrombolysis for acute ischaemic stroke
JM Wardlaw, V Murray, E Berge… - Cochrane database of …, 2014 - cochranelibrary.com
… EMBASE identified 3958 references, which included many additional publications to
trials that were already in the review, and several that were relevant to another review (Wardlaw …
trials that were already in the review, and several that were relevant to another review (Wardlaw …
[HTML][HTML] Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis
JM Wardlaw, V Murray, E Berge, G Del Zoppo… - The Lancet, 2012 - thelancet.com
Background Recombinant tissue plasminogen activator (rt-PA, alteplase) improved functional
outcome in patients treated soon after acute ischaemic stroke in randomised trials, but …
outcome in patients treated soon after acute ischaemic stroke in randomised trials, but …
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement
…, DF Kallmes, BFM Fitzsimmons, J Mocco, JM Wardlaw… - Stroke, 2013 - Am Heart Assoc
Methods A hybrid approach based on established processes described by Glaser15 and by
the National Institutes of Health (http://prevention. nih. gov/cdp/about. aspx) 16 was used to …
the National Institutes of Health (http://prevention. nih. gov/cdp/about. aspx) 16 was used to …
Blood–brain barrier: ageing and microvascular disease–systematic review and meta-analysis
AJ Farrall, JM Wardlaw - Neurobiology of aging, 2009 - Elsevier
… Contributions by both Dr Farrall and Prof Wardlaw include study design, search strategy
development, data extraction and analysis, and manuscript drafting and editing. Dr Farrall …
development, data extraction and analysis, and manuscript drafting and editing. Dr Farrall …
[BOOK][B] Stroke: practical management
…, J Van Gijn, MS Dennis, JM Wardlaw, JM Bamford… - 2011 - books.google.com
Completely updated edition, written by a close-knit author team Presents a unique approach
to stroke-integrated clinical management that weaves together causation, presentation, …
to stroke-integrated clinical management that weaves together causation, presentation, …
The detection and management of unruptured intracranial aneurysms
JM Wardlaw, PM White - Brain, 2000 - academic.oup.com
The incidence of subarachnoid haemorrhage (SAH) is 6–8 per 100 000 person years, peaking
in the sixth decade. SAH, mostly due to rupture of an intracranial aneurysm, accounts for …
in the sixth decade. SAH, mostly due to rupture of an intracranial aneurysm, accounts for …
[HTML][HTML] Brain age predicts mortality
…, RE Marioni, JM Starr, SR Cox, JM Wardlaw… - Molecular …, 2018 - nature.com
Age-associated disease and disability are placing a growing burden on society. However,
ageing does not affect people uniformly. Hence, markers of the underlying biological ageing …
ageing does not affect people uniformly. Hence, markers of the underlying biological ageing …